Applied Therapeutics APLT 深 沪
等待开盘 12-29 09:30:00 美东时间
0.1139
-0.001
-1.30%
华盛通- 最 高0.1139
- 今 开0.1098
- 成交量 672.60万股
- 最 低 0.108
- 昨 收 0.1154
- 总市值 1640.16万
- 52周最高 1.50
- 市盈率 静 --
- 换手率 4.67%
- 52周最低 0.10
- 委 比 -95.26%
- 总股本 1.44亿
- 历史最高 57.39
- 量 比 0.59
- 振 幅 5.11%
- 历史最低 0.10
- 每 手 1
- 风险率 0.27%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Verastem Oncology announces management changes
Verastem Oncology (NASDAQ:VSTM) announced on Monday strategic leadership changes to accelerate its next phase of growth. John Johnson has been appointed as chairman of the board of directors, succeedi...
12-16 05:34
Why Lululemon Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Shares of Lululemon Athletica Inc (NASDAQ:LULU) rose sharply in pre-market trad...
12-12 17:41
Cycle Pharmaceuticals to Acquire Applied Therapeutics
Applied Therapeutics, a biopharmaceutical company developing treatments for rare diseases, announced that Cycle Group Holdings will acquire the company. Cycle will offer $0.088 per share plus contingent value rights (CVRs) tied to regulatory approvals and sales milestones. The transaction, expected to close in early 2026, was approved by Applied’s board after evaluating strategic options. Applied’s lead drug, govorestat, targets rare CNS metaboli...
12-11 22:25
美股大行评级 | 美鹰服饰、CrowdStrike、迈威尔科技获多家机构上调目标价；ACHC、GitLab、Okta遭多家机构下调目标价
今日重点评级关注：Guggenheim：维持Cybin Inc. Common Shares"买入"评级，目标价从39美元升至48美元；HC Wainwright & Co.：维持Capricor Therapeutics"买入"评级，目标价从24美元升至60美元
12-04 09:38
Leerink Partners Downgrades Applied Therapeutics to Market Perform, Lowers Price Target to $1
Leerink Partners analyst Joseph Schwartz downgrades Applied Therapeutics (NASDAQ:APLT) from Outperform to Market Perform and lowers the price target from $2 to $1.
12-03 21:48
Applied Therapeutics Announces Strategic Review and Workforce Cuts
An announcement from Applied Therapeutics ( ($APLT) ) is now available. On Nove...
11-20 21:28
Applied Therapeutics Announces Corporate Updates
Applied Therapeutics, a clinical-stage biopharmaceutical company, announced it has initiated a process to explore strategic alternatives to maximize shareholder value, which may include mergers, acquisitions, partnerships, or other transactions. The company is also reducing its workforce by approximately 46% to conserve cash. The Board remains committed to acting in the best interests of all stockholders. Additionally, the company is engaging wit...
11-20 12:00
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Mersana Therapeutics (NASDAQ:MRSN) stock increased by 205.0% to $27.05...
11-14 01:06
Applied Therapeutics shares are trading lower. The company reported Q3 financial results.
Applied Therapeutics shares are trading lower. The company reported Q3 financia...
11-13 22:05
Applied Therapeutics Q3 EPS $(0.13) Beats $(0.14) Estimate, Sales $1.000M
Applied Therapeutics (NASDAQ:APLT) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 8.45 percent. This is a 72.92 percent increase over losses of $(0.48) per share
11-13 20:18
